首页 产品目录 分子砌块 按官能团 羧酸类 (3R,5R)-7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-(苯基氨基甲酰基)-1H-吡咯-1-基)-3,5-二羟基庚酸

(3R,5R)-7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-(苯基氨基甲酰基)-1H-吡咯-1-基)-3,5-二羟基庚酸

(3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
100mg 95% 询价
- +
250mg 95% 询价
- +
1g 95% 询价
- +
5g 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

134523-00-5

中文名称

(3R,5R)-7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-(苯基氨基甲酰基)-1H-吡咯-1-基)-3,5-二羟基庚酸

英文名称

(3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid

别名

Atorvastatin (Subject to Patent free);(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid;(3R,5R)-2-(4-Fluorophenyl)-3,5-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid;Atorvastatin free ACID;Atorvastatin&Ats-5Ats-8Ats-9M4L1;Atrovastitne;(bR,dR)-2-(p-Fluorophenyl)-β,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δR)-

标准英文名

(3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid

分子式

C33H35FN2O5

分子量

558.25

精确分子量

558.25

SMILES

O=C(C1=C(C(C)C)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C2=CC=C(C=C2)F)=C1C3=CC=CC=C3)NC4=CC=CC=C4

标准SMILES

CC(C)C1=C(C(=C(C2C=CC(F)=CC=2)N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1C=CC=CC=1)C(=O)NC1C=CC=CC=1

用途

Atorvastatin is used as a lipid-lowering agent; it inhibits HMG-CoA reductase activity, thereby reducing cholesterol synthesis; it is clinically used for the treatment of hypercholesterolemia and provides beneficial preventive effects in hypertension, coronary heart disease, and cerebrovascular diseases; it is used in patients with atherosclerosis to protect endothelial function, delay atherosclerosis progression, protect target organs, and improve prognosis; in patients with acute coronary syndrome, it reduces CRP levels and alleviates clinical symptoms; in hypertensive patients, it lowers CD40 and CD40L expression, exerts antihypertensive effects, and improves physiological comfort; in patients with acute cerebral infarction, it reduces high-sensitivity CRP levels and improves neurological deficits; in patients with subarachnoid hemorrhage, it inhibits caspase-3 and -5 expression, alleviates vasospasm, and promotes recovery; it exhibits multiple pharmacological effects including anti-atherosclerotic, anti-inflammatory, and antihypertensive actions.

InChIKey

XUKUURHRXDUEBC-KAYWLYCHSA-N

安全信息

SureRoute逆合成路线

1.  134523-00-5 逆合成路线 1

—
—
ACWEFX037
134523-00-5
来源: SureRoute

2.  134523-00-5 逆合成路线 2

—
—
ACQVKH312
1184-54-9
—
—
ACWEFX037
134523-00-5
来源: SureRoute

3.  134523-00-5 逆合成路线 3

—
—
—
—
—
—
ACWEFX037
134523-00-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手